Remember meForgot password?
    Log in with Twitter

oxymorphone hydrochloride News

FDA asks pharmaceutical company to pull opioid from drug market

On Thursday, the U.S. Food and Drug Administration (FDA) requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market due to concerns over abuse.

Search Digital Journal Archives

Set up a news alert for

oxymorphone hydrochloride

oxymorphone hydrochloride Image

Latest News
Top News